<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31454198</article-id><article-id pub-id-type="pmc">6713381</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0392</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Opium Addiction on Postoperative Arrhythmia Among Patients
Undergoing CABG operation on Cardiopulmonary Bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Basirat</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5631-4813</contrib-id><name><surname>Ziyaeifard</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Gorjipour</surname><given-names>Farhad</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>CCP</role></contrib><contrib contrib-type="author"><name><surname>Mehrabanian</surname><given-names>Mohammad Javad</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Attarzadeh</surname><given-names>Seyed Hassan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Nekoofard</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Mortazian</surname><given-names>Meysam</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Sary Branch, Islamic Azad University, Sary, Iran.</aff><aff id="aff2">
<label>2</label> Rajaie Cardiovascular, Medical and Research Center, Iran University
of Medical Sciences, Tehran, Iran.</aff><aff id="aff3">
<label>3</label> Tehran Heart Center, Tehran University of Medical Sciences, Tehran,
Iran.</aff><aff id="aff4">
<label>4</label> AJA University of Medical Sciences, Tehran, Iran.</aff><author-notes><corresp id="c1">Correspondence Address: Mohsen Ziyaeifard,
https://orcid.org/0000-0002-5631-4813, Rajaie Cardiovascular, Medical and
Research Center, Iran University of Medical Sciences, Tehran, Iran - Zip code:
14467. E-mail: <email>borhanresearch@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2019</year></pub-date><volume>34</volume><issue>4</issue><fpage>444</fpage><lpage>450</lpage><history><date date-type="received"><day>28</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objectives</title><p>Postoperative arrhythmia is an important complication of coronary artery
bypass grafting (CABG) surgeries among patients. It seems that opioid usage
is implicated in the pathogenesis of this condition due to its impacts on
different organ systems, such as the autonomic nervous system. The present
study was performed to investigate the effect of opium use on postoperative
arrhythmia in patients undergoing CABG surgery.</p></sec><sec><title>Methods</title><p>Study participants were selected via convenience sampling from patients
undergoing CABG surgery in a referral hospital. Study variables, including
use of inotropic drugs, vital signs monitoring parameters and postoperative
arrhythmia were observed and recorded at baseline and at follow-up time
after surgery.</p></sec><sec><title>Results</title><p>Sixty-five (14.8%) patients had postoperative arrhythmia, and 104
participants were addicted. Prevalence of postoperative arrhythmia was the
same among addict and non-addict patients. According to the regression
analysis model, only serum level of epinephrine in operating room, heart
rate and central venous pressure at baseline and 48 hours after operation
are known as independent predictors of postoperative arrhythmia among study
population.</p></sec><sec><title>Conclusion</title><p>This study showed that although opium addiction increased postoperative
arrhythmia among patients undergoing CABG surgery, this difference was not
significant, and this association is probably mediated by other study
variables.</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Arrhythmias, Cardiac</kwd><kwd>Opium Dependence</kwd><kwd>Central Venous Pressure</kwd><kwd>Epinephrine</kwd><kwd>Postoperative Period</kwd></kwd-group></article-meta></front><body><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery
disease</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiovascular
diseases</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Operating room</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">WHO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= World Health
Organization</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Prevalence of cardiovascular diseases (CVD) has increased in recent years. Fifty
percent of deaths in developed countries and 25% of deaths in developing countries
are related to CVD<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. According to the World Health Organization&#x02019;s (WHO)
reports, CVD causes one third of all annual deaths around the
world<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Coronary artery bypass grafting (CABG) surgery is
performed in CVD patients to improve their outcomes and to decrease incidence of
mortality. Postoperative arrhythmia is one of the CABG complications, and different
studies have been performed to the management of this complication among patients
undergoing cardiopulmonary surgery<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>Drug addiction is known as one of the major social health problems in the world.
Opium dependence is highly prevalent among Iranian drug
abusers<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>]</sup>. As an example, according to a large clinical
survey, around 5.2% of Iranian patients with CVD were
opium-dependent<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. It seems that there is a misconception among
Iranian population that opium usage might decrease adverse impacts of hypertension,
diabetes mellitus and CVD<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p><p>Although most of the effects of opium are focused on the central and autonomic
nervous system and the intestinal tract, opium usage may have impacts on some other
organ systems, such as respiratory and cardiovascular systems<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Effects of opium usage
on the cardiovascular system are known to be mediated by some endogenous ligands as
opioid peptides<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Opioid peptides interact with most of the
pathophysiological cardiac outcomes, such as tachycardia/bradycardia,
hypotension/hypertension, and vasodilation. According to our search in the
literature, there were few papers available regarding impacts of opioid usage on
postoperative outcomes such as arrhythmia. We assumed that opioid usage, due to its
impacts on different organs, such as autonomic nervous system, is potentially a risk
factor in postoperative arrhythmia among patients undergoing cardiac surgeries. The
present study was performed to evaluate the effect of opium consumption on
postoperative arrhythmia among patients undergoing CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design and Patient Selection</title><p>Present clinical research was performed on patients undergoing CABG surgery in
Rajaie Cardiovascular Medical and Research Center (Tehran, Iran). Study
population was selected via convenience sampling from patients who were referred
to heart surgery clinic for CVD management and were candidates for elective CABG
surgery. Study inclusion criteria were elective CABG surgery, age between 18 and
85 years, male or female. Patients with prior history of cardiopulmonary bypass,
known cardiac rhythm disturbances, use of pacemakers or advanced heart failure
were excluded from the study. Study protocol was designed according to the
Declaration of Helsinki and was approved by the Ethics Committee of Iran
University of Medical Sciences. Informed consent was obtained from all study
participants before starting the trial.</p></sec><sec><title>Data Collection</title><p>Data related to patient demographics and history were extracted and recorded in
standard checklists. Then a checklist for each patient was used for data
collection, and data were taken and recorded by a nursing professional. Use of
inotropic drugs such as epinephrine, norepinephrine, dopamine, milrinone and
dobutamine before, during and after surgery was recorded. Vital signs, including
systolic and diastolic blood pressure, heart rate and central venous pressure,
were measured at baseline, after surgery, in the ICU admission, and 6, 24 and 48
hours after surgery. Heart rhythm of the patients was assessed until 72 hours
after operation and occurrence of dysrhythmia was recorded, and their types were
assessed as dependent variables.</p><p>Patients were grouped according to the status of opium addiction or the status of
arrhythmias after operation.</p></sec><sec><title>Statistical Analysis</title><p>Data were analyzed using SPSS V20 software for statistical analysis. Frequencies
of study variables were compared in the two groups with chi-square and
<italic>odds ratio</italic>. Quantitative variables were presented as mean
&#x000b1; standard deviation, and qualitative variables were presented as
frequencies and frequency percentage. Independent sample Student&#x02019;s t-test was
used for comparing the mean of continuous study variables between the two
groups. We used logistic regression model to assess the role of study variables
in the incidence of postoperative arrhythmia. We included all variables that had
a <italic>P</italic>-value &#x0003c;0.2 in their univariate association with
postoperative arrhythmia. All <italic>P</italic>-values &#x0003c;0.05 were assumed as
significant results.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Finally, 438 patients (222 female) met our inclusion criteria and were included in
the trial. Mean age, body mass index and preoperative left ventricle ejection
fraction were 61.23&#x000b1;9.05 years, 25.26&#x000b1;4.54 kg/m<sup>2</sup> and
41.91%&#x000b1;9.26%, respectively. Among trial participants, 306 patients (69.7%)
had comorbidities including diabetes (47.6%), hypertension (56.9%), thyroid
disorders (6.6%), and renal (9.3%) and neurological lesions (4.6%). The mean surgery
time was 265.02&#x000b1;76.61 minutes and the mean cardiopulmonary bypass (CPB) time
was 86.57&#x000b1;32.85. Among comorbidities, only diabetes
(<italic>P</italic>=0.008) had a significant association. Hypertension
(<italic>P</italic>=0.34), thyroid (<italic>P</italic>=0.16), neurological
(<italic>P</italic>=0.67) and renal disorders (<italic>P</italic>=0.08) had no
significant association with the incidence of postoperative arrhythmia.</p><p>In total, 104 participants (23.8%) were addicted. Mean CPB time (89.16&#x000b1;3.02
<italic>vs</italic>. 85.89&#x000b1;31.95; <italic>P</italic>=0.59) and mean
cross-clamping time (49.15&#x000b1;24.01 <italic>vs</italic>. 45.83&#x000b1;20.40;
<italic>P</italic>=0.38) among addict patients were not significantly lower than
other patients. The mean surgery time among addict patients was significantly lower
than other patients (248.85&#x000b1;80.02 <italic>vs</italic>. 269.60&#x000b1;74.94;
<italic>P</italic>=0.03). Among inotropic drugs, only mean of epinephrine
(<italic>P</italic>=0.02) and dopamine (<italic>P</italic>=0.01) in operating
room (OR) were significantly different among patients with postoperative arrhythmia
and other patients. When comparing the use of inotropic drugs among addicts and
other patients, except epinephrine in OR and ICU, other drugs did not present
significant changes (<xref rid="t1" ref-type="table">Tables 1</xref> and <xref rid="t2" ref-type="table">2</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Inotropic and anticoagulant drug usage between study population with and
without postoperative arrhythmia.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">POA (+)</th><th align="center" rowspan="1" colspan="1">POA (-)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value<sup><xref ref-type="table-fn" rid="TFN1">*</xref></sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Epinephrine in OR</td><td align="center" rowspan="1" colspan="1">0.77&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">0.84&#x000b1;0.37</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Epinephrine in ICU</td><td align="center" rowspan="1" colspan="1">0.74&#x000b1;0.44</td><td align="center" rowspan="1" colspan="1">0.83&#x000b1;0.37</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Norepinephrine in OR </td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.11</td><td align="center" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Norepinephrine in ICU</td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.11</td><td align="center" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Dopamine in OR</td><td align="center" rowspan="1" colspan="1">0.94&#x000b1;0.24</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Dopamine in ICU</td><td align="center" rowspan="1" colspan="1">0.96&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.14</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Milrinone in OR</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.09</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Milrinone in ICU</td><td align="center" rowspan="1" colspan="1">1.01&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.09</td><td align="center" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" rowspan="1" colspan="1">Dobutamine in OR</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.11</td><td align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Dobutamine in ICU</td><td align="center" rowspan="1" colspan="1">1.0&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">0.55</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p><italic>P</italic>-value was calculated according to independent
Student's t-test</p></fn><fn id="TFN2"><p>ICU=intensive care unit; OR=operating room; POA=postoperative
arrhythmia</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Inotropic and anticoagulant drug usage between study population.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Addict patients&#x000a0;</th><th align="center" rowspan="1" colspan="1">Non-addict patients</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value<sup><xref ref-type="table-fn" rid="TFN3">*</xref></sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Epinephrine in OR</td><td align="center" rowspan="1" colspan="1">0.92&#x000b1;0.27</td><td align="center" rowspan="1" colspan="1">0.78&#x000b1;0.41</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Epinephrine in ICU</td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.11</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Norepinephrine in OR </td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.11&#x000b1;0.98</td><td align="center" rowspan="1" colspan="1">0.263</td></tr><tr><td align="left" rowspan="1" colspan="1">Norepinephrine in ICU</td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.11</td><td align="center" rowspan="1" colspan="1">0.263</td></tr><tr><td align="left" rowspan="1" colspan="1">Dopamine in OR</td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.97&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.091</td></tr><tr><td align="left" rowspan="1" colspan="1">Dopamine in ICU</td><td align="center" rowspan="1" colspan="1">1&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.96&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.091</td></tr><tr><td align="left" rowspan="1" colspan="1">Milrinone in OR</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.09</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.084</td></tr><tr><td align="left" rowspan="1" colspan="1">Milrinone in ICU</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">0.34&#x000b1;0.91</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">Dobutamine in OR</td><td align="center" rowspan="1" colspan="1">1.0&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.98&#x000b1;0.13</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Dobutamine in ICU</td><td align="center" rowspan="1" colspan="1">1.0&#x000b1;0.001</td><td align="center" rowspan="1" colspan="1">0.99&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">0.42</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>*</label><p><italic>P</italic>-value was calculated according to independent
Student's t-test. </p></fn><fn id="TFN4"><p>ICU=intensive care unit; OR=operating room</p></fn></table-wrap-foot></table-wrap><p>To see if there is a difference between addict and non-addict patients, they were
divided into two groups and compared for their demographic information. No
significant differences were found between the two groups according to their
demographics (<xref rid="t3" ref-type="table">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of demographic variables between addict and non-addict study
population.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Addict patients (n=104)</th><th align="center" rowspan="1" colspan="1">Non-addict patients (n=332)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value<sup><xref ref-type="table-fn" rid="TFN5">*</xref></sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">60.36&#x000b1;8.69</td><td align="center" rowspan="1" colspan="1">61.49&#x000b1;9.17</td><td align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">25.94&#x000b1;4.72</td><td align="center" rowspan="1" colspan="1">26.38&#x000b1;4.49</td><td align="center" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (male)</td><td align="center" rowspan="1" colspan="1">53 (24.7%)</td><td align="center" rowspan="1" colspan="1">162 (75.3%)</td><td align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">52 (25.1%)</td><td align="center" rowspan="1" colspan="1">155 (74.9%)</td><td align="center" rowspan="1" colspan="1">0.56</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension </td><td align="center" rowspan="1" colspan="1">62 (24.9%)</td><td align="center" rowspan="1" colspan="1">187 (75.1%)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Thyroid disorders </td><td align="center" rowspan="1" colspan="1">3 (10.7%)</td><td align="center" rowspan="1" colspan="1">25 (89.3%)</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological lesions</td><td align="center" rowspan="1" colspan="1">4 (20%)</td><td align="center" rowspan="1" colspan="1">16 (80%)</td><td align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal lesions</td><td align="center" rowspan="1" colspan="1">12 (29.3%)</td><td align="center" rowspan="1" colspan="1">29 (70.7%)</td><td align="center" rowspan="1" colspan="1">0.40</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>*</label><p><italic>P</italic>-value was calculated according to independent
Student's t-test and chi-square test.</p></fn></table-wrap-foot></table-wrap><p>In this study, 65 (14.8%) patients had postoperative arrhythmia. Prevalence of
postoperative arrhythmia was similar among addict and non-addict patients (15, 14.4%
<italic>vs</italic>. 50, 15.1%; OR: 0.96 95% CI: 0.56-1.63;
<italic>P</italic>=0.87). When accounting for the type of arrhythmia, there were
also no significant differences between patients with and without history of opium
addiction. Mean age (60.01&#x000b1;8.39 <italic>vs</italic>. 61.29&#x000b1;9.06;
<italic>P</italic>=0.74) and mean body mass index (26.18&#x000b1;3.46
<italic>vs</italic>. 26.26&#x000b1;4.56; <italic>P</italic>=0.96) were similar
between patients with and without postoperative arrhythmia. Premature ventricular
contractions are the most prevalent arrhythmias in both groups, followed by atrial
fibrillation. However, there was no significant difference between the two groups in
terms of type of arrhythmia (<xref ref-type="fig" rid="f1">Figure 1</xref>).
Systolic and diastolic blood pressure and heart rate at baseline, systolic blood
pressure at 6 and 48 hours after surgery and heart rate in the ICU admission were
significantly different among patients with postoperative arrhythmia and other
patients (<xref rid="t4" ref-type="table">Table 4</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Frequency percentage of patients with each type of arrhythmia in patients
with and without drug addiction. There were no statistically significant
differences between the two groups in the arrhythmia type. AF=atrial
fibrillation; PVC=premature ventricular contractions</p></caption><graphic xlink:href="rbccv-34-04-0444-g01"/></fig>
</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Comparing blood pressure and heart rate among study population in different
study points between patients with and without postoperative arrhythmia.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">POA (+)</th><th align="center" rowspan="1" colspan="1">POA (-)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SBP at baseline</td><td align="center" rowspan="1" colspan="1">135.36&#x000b1;22.54</td><td align="center" rowspan="1" colspan="1">123.32&#x000b1;19.63</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP at baseline</td><td align="center" rowspan="1" colspan="1">75.18&#x000b1;11.78</td><td align="center" rowspan="1" colspan="1">71.14&#x000b1;12.33</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP after surgery</td><td align="center" rowspan="1" colspan="1">120.74&#x000b1;16.24</td><td align="center" rowspan="1" colspan="1">116.64&#x000b1;18.30</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP after surgery</td><td align="center" rowspan="1" colspan="1">70.64&#x000b1;18.30</td><td align="center" rowspan="1" colspan="1">69.02&#x000b1;11.93</td><td align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP at ICU admission</td><td align="center" rowspan="1" colspan="1">119.03&#x000b1;23.86</td><td align="center" rowspan="1" colspan="1">116.43&#x000b1;21.09</td><td align="center" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP at ICU admission</td><td align="center" rowspan="1" colspan="1">68.81&#x000b1;11.69</td><td align="center" rowspan="1" colspan="1">66.52&#x000b1;13.49</td><td align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP 6 hours later</td><td align="center" rowspan="1" colspan="1">120.59&#x000b1;17.01</td><td align="center" rowspan="1" colspan="1">114.19&#x000b1;14.04</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP 6 hours later</td><td align="center" rowspan="1" colspan="1">69.29&#x000b1;11.39</td><td align="center" rowspan="1" colspan="1">66.05&#x000b1;12.73</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP 24 hours later</td><td align="center" rowspan="1" colspan="1">118.94&#x000b1;17.69</td><td align="center" rowspan="1" colspan="1">115.58&#x000b1;14.73</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP 24 hours later</td><td align="center" rowspan="1" colspan="1">68.62&#x000b1;16.76</td><td align="center" rowspan="1" colspan="1">66.40&#x000b1;11.84</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP 48 hours later</td><td align="center" rowspan="1" colspan="1">121.51&#x000b1;20.55</td><td align="center" rowspan="1" colspan="1">117.28&#x000b1;13.56</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP 48 hours later</td><td align="center" rowspan="1" colspan="1">70.01&#x000b1;11.34</td><td align="center" rowspan="1" colspan="1">66.95&#x000b1;12.62</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">HR at baseline</td><td align="center" rowspan="1" colspan="1">75.65&#x000b1;11.28</td><td align="center" rowspan="1" colspan="1">79.20&#x000b1;11.12</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">HR after surgery</td><td align="center" rowspan="1" colspan="1">82.65&#x000b1;11.28</td><td align="center" rowspan="1" colspan="1">83.97&#x000b1;11.53</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">HR at ICU admission</td><td align="center" rowspan="1" colspan="1">91.66&#x000b1;16.64</td><td align="center" rowspan="1" colspan="1">86.10&#x000b1;13.45</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">HR 6 hours later</td><td align="center" rowspan="1" colspan="1">87.17&#x000b1;16.64</td><td align="center" rowspan="1" colspan="1">84.96&#x000b1;10.83</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">HR 24 hours later</td><td align="center" rowspan="1" colspan="1">86.51&#x000b1;16.50</td><td align="center" rowspan="1" colspan="1">83.23&#x000b1;11.21</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">HR 48 hours later</td><td align="center" rowspan="1" colspan="1">83.38&#x000b1;14.28</td><td align="center" rowspan="1" colspan="1">83.18&#x000b1;10.08</td><td align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP at baseline</td><td align="center" rowspan="1" colspan="1">13.73&#x000b1;15.45</td><td align="center" rowspan="1" colspan="1">11.35&#x000b1;9.96</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP after surgery</td><td align="center" rowspan="1" colspan="1">10.42&#x000b1;2.65</td><td align="center" rowspan="1" colspan="1">9.72&#x000b1;2.86</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP at ICU admission</td><td align="center" rowspan="1" colspan="1">10.62&#x000b1;4.21</td><td align="center" rowspan="1" colspan="1">10.38&#x000b1;3.88</td><td align="center" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP 6 hours after surgery</td><td align="center" rowspan="1" colspan="1">11.63&#x000b1;3.44</td><td align="center" rowspan="1" colspan="1">12.61&#x000b1;8.36</td><td align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP 24 hours after surgery</td><td align="center" rowspan="1" colspan="1">14.32&#x000b1;5.82</td><td align="center" rowspan="1" colspan="1">14.02&#x000b1;12.43</td><td align="center" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP 48 hours after surgery</td><td align="center" rowspan="1" colspan="1">14.01&#x000b1;3.78</td><td align="center" rowspan="1" colspan="1">13.01&#x000b1;3.46</td><td align="center" rowspan="1" colspan="1">0.06</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>CVP=central venous pressure; DBP=diastolic blood pressure; HR=heart rate;
ICU=intensive care unit; POA=postoperative arrythmia; SBP=systolic blood
pressure</p></fn></table-wrap-foot></table-wrap><sec><title>Logistic Regression Analysis Findings</title><p>After the inclusion of selected variables in the logistic regression model, only
serum levels of epinephrine in OR, heart rate and central venous pressure at
baseline and 48 hours after surgery remained in the regression model and were
known as independent predictors of postoperative arrhythmia among the study
population (<xref rid="t5" ref-type="table">Table 5</xref>).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Regression analysis for determination of independent predictors of
postoperative arrhythmia among study participants.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Included variables</th><th align="center" rowspan="2" colspan="1">B</th><th align="center" rowspan="2" colspan="1"><italic>P</italic>-value</th><th align="center" rowspan="2" colspan="1">Exp (B)</th><th align="center" colspan="2" rowspan="1">95% CI for Exp (B)</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower</th><th align="center" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">-0.04</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery time</td><td align="center" rowspan="1" colspan="1">-0.003</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">1.005</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes (1)</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">0.58</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">5.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Thyroid (1)</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">1.59</td><td align="center" rowspan="1" colspan="1">0.22</td><td align="center" rowspan="1" colspan="1">11.52</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal (1)</td><td align="center" rowspan="1" colspan="1">-1.98</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">0.017</td><td align="center" rowspan="1" colspan="1">1.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Epinephrine in OR</td><td align="center" rowspan="1" colspan="1">-1.67</td><td align="center" rowspan="1" colspan="1">0.091</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">0.027</td><td align="center" rowspan="1" colspan="1">1.30</td></tr><tr><td align="left" rowspan="1" colspan="1">Epinephrine in ICU</td><td align="center" rowspan="1" colspan="1">2.5</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">12.55</td><td align="center" rowspan="1" colspan="1">1.83</td><td align="center" rowspan="1" colspan="1">86.37</td></tr><tr><td align="left" rowspan="1" colspan="1">Dopamine in OR</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.59</td><td align="center" rowspan="1" colspan="1">2.44</td><td align="center" rowspan="1" colspan="1">0.095</td><td align="center" rowspan="1" colspan="1">62.54</td></tr><tr><td align="left" rowspan="1" colspan="1">Milrinone in OR</td><td align="center" rowspan="1" colspan="1">24.68</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">5.24</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP at baseline </td><td align="center" rowspan="1" colspan="1">-0.007</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">1.03</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP at baseline</td><td align="center" rowspan="1" colspan="1">-0.054</td><td align="center" rowspan="1" colspan="1">0.15</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.88</td><td align="center" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative SBP</td><td align="center" rowspan="1" colspan="1">-0.022</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.94</td><td align="center" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP 6 hours after surgery</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">1.004</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">1.04</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP 6 hours after surgery</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">1.009</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">1.06</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP 48 hours after surgery</td><td align="center" rowspan="1" colspan="1">-0.013</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">1.03</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP 48 hours after surgery</td><td align="center" rowspan="1" colspan="1">-0.026</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.93</td><td align="center" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1">HR at baseline</td><td align="center" rowspan="1" colspan="1">0.058</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">1.06</td><td align="center" rowspan="1" colspan="1">1.002</td><td align="center" rowspan="1" colspan="1">1.122</td></tr><tr><td align="left" rowspan="1" colspan="1">HR at ICU</td><td align="center" rowspan="1" colspan="1">-0.019</td><td align="center" rowspan="1" colspan="1">0.37</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.94</td><td align="center" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" rowspan="1" colspan="1">HR 6 hours after surgery</td><td align="center" rowspan="1" colspan="1">0.040</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">1.04</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">1.11</td></tr><tr><td align="left" rowspan="1" colspan="1">HR 24 hours after surgery</td><td align="center" rowspan="1" colspan="1">-0.93</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.86</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP baseline</td><td align="center" rowspan="1" colspan="1">-0.050</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative CVP</td><td align="center" rowspan="1" colspan="1">-0.084</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.73</td><td align="center" rowspan="1" colspan="1">1.15</td></tr><tr><td align="left" rowspan="1" colspan="1">CVP 48 hours after surgery</td><td align="center" rowspan="1" colspan="1">-0.175</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Constant</td><td align="center" rowspan="1" colspan="1">-5.480</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.0040</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>CVP=central venous pressure; DBP=diastolic blood pressure; HR=heart
rate; ICU=intensive care unit; OR=operating room; SBP=systolic blood
pressure</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, 65 (14.8%) patients presented postoperative arrhythmia and 104
participants were addicted. Prevalence of postoperative arrhythmia was similar among
addict and non-addict patients. According to the regression analysis model, only
serum levels of epinephrine in OR, heart rate and central venous pressure level at
baseline and 48 hours after surgery were demonstrated to be independent predictors
of postoperative arrhythmia among study population.</p><p>There were several studies which reported opium addiction among different
populations<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>. As an example, prevalence of smoking was 38.5%
among Iranian patients undergoing surgery<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. In one study, the prevalence of
smoking among CABG patients was 37.5%<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. There are different studies with
conflicting findings on the association of smoking or opium addiction with CABG
postoperative outcomes. Many similar studies reported that higher morbidity and
mortality rates were found among smokers than nonsmokers after cardiac
surgery<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Although most studies reported that the risk of
CAD increased with opium usage, in one study in 2004, CAD severity was lower among
methadone or opiate users in comparison with other patients. On the other hand,
researchers believed that long-time opium exposure can decline the severity of CAD
and fatal outcome<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>Our study findings showed similar postoperative arrhythmia among addict and
non-addict participant patients. We discussed cautiously about findings of similar
studies due to lack of some essential information, such as history of smoking, lipid
profile, and lifestyle among addict patients. In other studies, opium usage has been
shown an independent predictor of coronary artery disorders among patients and has
even correlated with the number of diseased vessels<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. In another study,
investigators found that opium consumption was a major risk factor for acute
myocardial infarction<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. When comparing the operating time between two
groups of addict and non-addict patients, a significantly shorter surgery time was
observed in addicts. This difference may be due to chance or due to the patients&#x02019;
tolerance to analgesics and opioid anesthetics or other analogs. However, regression
analysis revealed no relationship between surgery time and the occurrence of
arrhythmias postoperatively in the present study.</p><p>Different studies in the literature compare outcomes of CABG surgery among opium
users and other patients. They reported that postoperative complications and
duration of hospital stay were similar between the two groups, but opium users were
more likely than other patients to be readmitted in the hospital due to cardiac
complications during the six-month follow-up<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Some methodological bias is found
among these clinical studies. Most of the studies had case-control or
cross-sectional design. Although a higher prevalence of opium consumption observed
among patients with coronary artery disease than in controls, a causal
interpretation is not warranted due to the gap between occurrence and exposure
times.</p><p>Another significant observation was the higher consumption of inotropic agents in
patients without postoperative arrhythmia. This observation can be described as a
consequence of hemodynamic instability and lower preoperative blood pressure in
these patients. Consumption of these agents was also higher in addicts in the OR and
in the ICU. This is probably due to the higher doses of opioids required for
analgesia in these patients. Moreover, some of them probably abuse more of these
opioids in the hospital without the physician&#x02019;s order. Therefore, these patients
will present lower blood pressure and will need epinephrine administration to
stabilize the hemodynamics.</p><p>However, interpretation of the findings of the present study must be very
conservative and inferences about the relationship between these variables are
limited to an association rather than to causality. Cohort or longitudinal study for
approving causal association of opium addiction and postoperative outcomes among
patients undergoing cardiac surgery is warranted.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Our study demonstrated that despite the increase in the rate of postoperative
arrhythmia among opium-addicted patients undergoing CABG surgery, this difference
was not significant, and this association is mediated by other study variables.</p><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author's roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MZ</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FG</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MJM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SHA</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MN</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MM</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising
it critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Iran University of Medical Sciences, Tehran,
Iran.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gaziano</surname><given-names>J</given-names></name></person-group><chapter-title>Global burden of cardiovascular disease</chapter-title><person-group person-group-type="editor"><name><surname>Zipes</surname><given-names>D</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Bonow</surname><given-names>R</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group><source>Braunwald's Heart Disease</source><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier Saunders</publisher-name><year>2005</year><fpage>423</fpage><lpage>455</lpage></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firoozabadi</surname><given-names>MD</given-names></name><name><surname>Ebadi</surname><given-names>A</given-names></name><name><surname>Ebadi</surname><given-names>M</given-names></name><name><surname>Ebadi</surname><given-names>S</given-names></name><name><surname>Ahvaz</surname><given-names>I</given-names></name></person-group><article-title>Prevalence risk factors in three vessel disease patients
candidate for coronary-artery bypass surgery</article-title><source>Life Sci J</source><year>2014</year><volume>11</volume><issue>12s</issue><fpage>67</fpage><lpage>70</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiryakioglu</surname><given-names>O</given-names></name><name><surname>Demirtas</surname><given-names>S</given-names></name><name><surname>Ari</surname><given-names>H</given-names></name><name><surname>Tiryakioglu</surname><given-names>SK</given-names></name><name><surname>Huysal</surname><given-names>K</given-names></name><name><surname>Selimoglu</surname><given-names>O</given-names></name><etal/></person-group><article-title>Magnesium sulphate and amiodarone prophylaxis for prevention of
postoperative arrhythmia in coronary by-pass operations</article-title><source>J Cardiothorac Surg</source><year>2009</year><volume>4</volume><fpage>8</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1749-8090-4-8</pub-id><pub-id pub-id-type="pmid">19232084</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>YT</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Wetzel</surname><given-names>G</given-names></name></person-group><article-title>Postoperative arrhythmia</article-title><source>Curr Opin Cardiol</source><year>2003</year><volume>18</volume><issue>2</issue><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">12652209</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeghian</surname><given-names>S</given-names></name><name><surname>Darvish</surname><given-names>S</given-names></name><name><surname>Davoodi</surname><given-names>G</given-names></name><name><surname>Salarifar</surname><given-names>M</given-names></name><name><surname>Mahmoodian</surname><given-names>M</given-names></name><name><surname>Fallah</surname><given-names>N</given-names></name><etal/></person-group><article-title>The association of opium with coronary artery
disease</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2007</year><volume>14</volume><issue>5</issue><fpage>715</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1097/HJR.0b013e328045c4e9</pub-id><pub-id pub-id-type="pmid">17925633</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>J</given-names></name><name><surname>Toobaee</surname><given-names>S</given-names></name><name><surname>Kharras</surname><given-names>M</given-names></name><name><surname>Radmehr</surname><given-names>M</given-names></name></person-group><article-title>Psychiatric disorders in opioid dependants</article-title><source>Int J Soc Psychiatry</source><year>2003</year><volume>49</volume><issue>3</issue><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1177/00207640030493004</pub-id><pub-id pub-id-type="pmid">14626361</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro Pinto</surname><given-names>LF</given-names></name><name><surname>Swann</surname><given-names>PF</given-names></name></person-group><article-title>Opium and oesophageal cancer: effect of morphine and opium on the
metabolism of N-nitrosodimethylamine and N-nitrosodiethylamine in the
rat</article-title><source>Carcinogenesis</source><year>1997</year><volume>18</volume><issue>2</issue><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1093/carcin/18.2.365</pub-id><pub-id pub-id-type="pmid">9054630</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safaii</surname><given-names>N</given-names></name><name><surname>Kazemi</surname><given-names>B</given-names></name></person-group><article-title>Effect of opium use on short-term outcome in patients undergoing
coronary artery bypass surgery</article-title><source>Gen Thorac Cardiovasc Surg</source><year>2010</year><volume>58</volume><issue>2</issue><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1007/s11748-009-0529-7</pub-id><pub-id pub-id-type="pmid">20155341</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalant</surname><given-names>H</given-names></name></person-group><article-title>Opium revisited: a brief review of its nature, composition, non
medical use and relative risks</article-title><source>Addiction</source><year>1997</year><volume>92</volume><issue>3</issue><fpage>267</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.1997.tb03197.x</pub-id><pub-id pub-id-type="pmid">9219389</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Brink</surname><given-names>OW</given-names></name><name><surname>Delbridge</surname><given-names>LM</given-names></name><name><surname>Rosenfeldt</surname><given-names>FL</given-names></name><name><surname>Penny</surname><given-names>D</given-names></name><name><surname>Esmore</surname><given-names>DS</given-names></name><name><surname>Quick</surname><given-names>D</given-names></name><etal/></person-group><article-title>Endogenous cardiac opioids: enkephalins in adaptation and
protection of the heart</article-title><source>Heart Lung Circ</source><year>2003</year><volume>12</volume><issue>3</issue><fpage>178</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1046/j.1444-2892.2003.00240.x</pub-id><pub-id pub-id-type="pmid">16352129</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasliwal</surname><given-names>R</given-names></name><name><surname>Kulshreshtha</surname><given-names>A</given-names></name><name><surname>Agrawal</surname><given-names>S</given-names></name><name><surname>Bansal</surname><given-names>M</given-names></name><name><surname>Trehan</surname><given-names>N</given-names></name></person-group><article-title>Prevalence of cardiovascular risk factors in Indian patients
undergoing coronary artery bypass surgery</article-title><source>J Assoc Physicians India</source><year>2006</year><volume>54</volume><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1097/00149831-200605001-00058</pub-id><pub-id pub-id-type="pmid">16909733</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M</given-names></name><name><surname>Mortasawi</surname><given-names>A</given-names></name><name><surname>Grayson</surname><given-names>A</given-names></name><name><surname>Oo</surname><given-names>A</given-names></name></person-group><article-title>Effect of smoking status on mortality and morbidity following
coronary artery bypass surgery</article-title><source>Thorac Cardiovasc Surg</source><year>2004</year><volume>52</volume><issue>5</issue><fpage>268</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1055/s-2004-821103</pub-id><pub-id pub-id-type="pmid">15470607</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>J</given-names></name><name><surname>Benrazavi</surname><given-names>L</given-names></name></person-group><article-title>Substance use among Iranian surgical patients</article-title><source>Int J Drug Policy</source><year>2002</year><volume>13</volume><issue>6</issue><fpage>509</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/S0955-3959(02)00064-6</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>J</given-names></name><name><surname>Benrazavi</surname><given-names>L</given-names></name></person-group><article-title>Substance use among Iranian cardiovascular
patients</article-title><source>Eur J Med Res</source><year>2002</year><volume>7</volume><issue>2</issue><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11891150</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Sarraf</surname><given-names>N</given-names></name><name><surname>Thalib</surname><given-names>L</given-names></name><name><surname>Hughes</surname><given-names>A</given-names></name><name><surname>Tolan</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>V</given-names></name><name><surname>McGovern</surname><given-names>E</given-names></name></person-group><article-title>Effect of smoking on short-term outcome of patients undergoing
coronary artery bypass surgery</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>86</volume><issue>2</issue><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.03.070</pub-id><pub-id pub-id-type="pmid">18640326</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marmor</surname><given-names>M</given-names></name><name><surname>Penn</surname><given-names>A</given-names></name><name><surname>Widmer</surname><given-names>K</given-names></name><name><surname>Levin</surname><given-names>RI</given-names></name><name><surname>Maslansky</surname><given-names>R</given-names></name></person-group><article-title>Coronary artery disease and opioid use</article-title><source>Am J Cardiol</source><year>2004</year><volume>93</volume><issue>10</issue><fpage>1295</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2004.01.072</pub-id><pub-id pub-id-type="pmid">15135709</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeghian</surname><given-names>S</given-names></name><name><surname>Graili</surname><given-names>P</given-names></name><name><surname>Salarifar</surname><given-names>M</given-names></name><name><surname>Karimi</surname><given-names>AA</given-names></name><name><surname>Darvish</surname><given-names>S</given-names></name><name><surname>Abbasi</surname><given-names>SH</given-names></name></person-group><article-title>Opium consumption in men and diabetes mellitus in women are the
most important risk factors of premature coronary artery disease in
Iran</article-title><source>Int J Cardiol</source><year>2010</year><volume>141</volume><issue>1</issue><fpage>116</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2008.11.063</pub-id><pub-id pub-id-type="pmid">19346018</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safaei</surname><given-names>N</given-names></name></person-group><article-title>Outcomes of coronary artery bypass grafting in patients with a
history of opiate use</article-title><source>Pak J Biol Sci</source><year>2008</year><volume>11</volume><issue>22</issue><fpage>2594</fpage><lpage>2598</lpage><pub-id pub-id-type="doi">10.3923/pjbs.2008.2594.2598</pub-id><pub-id pub-id-type="pmid">19260339</pub-id></element-citation></ref></ref-list></back></article>